Literature DB >> 2598046

Role of the cerebellum in the ontogenesis of the equilibrium behavior in the young rat: a behavioral study.

N Auvray1, J Caston, A Reber, T Stelz.   

Abstract

Young cerebellectomized and control DA/HAN strained rats, one day to 1 month old, were submitted to an equilibrium test. Cerebellectomized animals, operated when 10-, 20- or 24-day-old, were either trained-operated-trained (trained every day before and after cerebellectomy), naïve-operated-trained (cerebellectomized while naïve and trained every day after the operation), or naïve-operated-naïve (tested at one given day after the operation). Control rats were either trained-controls (trained every day) or naïve-controls (tested at a given day). Relevant comparisons show that (1) in control rats, the maturation of the equilibrium behavior does not depend on a specific training, at least to a great extent; however, training increases the rate of acquisition of the maximal score. (2) Rats cerebellectomized at day 10 and trained after cerebellectomy only are not able to learn a given motor pattern, while rats cerebellectomized by the 20th or 24th day are; however, their scores are always lower than those of control animals trained from the same age. Cerebellectomy alters the ontogenesis of the equilibrium behavior more especially as the operation is early. (3) Impairments of the equilibrium behavior after cerebellectomy can be explained by both motor disorders and learning processes deficiency. (4) Preoperative training counterbalances the effects of cerebellectomy in improving postoperative scores only when the cerebellum is removed at day 24. From these results it can be concluded that, in the rat, the cerebellum is involved in the learning processes that sustain the ontogenesis of the equilibrium behavior as it is in other motor learning mechanisms.

Entities:  

Mesh:

Year:  1989        PMID: 2598046     DOI: 10.1016/0006-8993(89)91455-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice.

Authors:  M Steinmayr; E André; F Conquet; L Rondi-Reig; N Delhaye-Bouchaud; N Auclair; H Daniel; F Crépel; J Mariani; C Sotelo; M Becker-André
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

2.  Perinatal exposure to polychlorinated biphenyls differentially affects cerebellar development and motor functions in male and female rat neonates.

Authors:  K Nguon; M G Baxter; E M Sajdel-Sulkowska
Journal:  Cerebellum       Date:  2005       Impact factor: 3.847

Review 3.  Exploring the cerebellum with a new tool: neonatal Borna disease virus (BDV) infection of the rat's brain.

Authors:  Mikhail V Pletnikov; Steven A Rubin; Timothy H Moran; Kathryn M Carbone
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

4.  Exposure to Altered Gravity During Specific Developmental Periods Differentially Affects Growth, Development, the Cerebellum and Motor Functions in Male and Female Rats.

Authors:  K Nguon; B Ladd; E M Sajdel-Sulkowska
Journal:  Adv Space Res       Date:  2006       Impact factor: 2.152

5.  Effects of lesion of the inferior olivary complex by 3-acetylpyridine on learning and memory in the rat.

Authors:  M Dahhaoui; T Stelz; J Caston
Journal:  J Comp Physiol A       Date:  1992-12       Impact factor: 1.836

6.  Behavioral tests in rodent models of stroke.

Authors:  Jingsong Ruan; Yao Yao
Journal:  Brain Hemorrhages       Date:  2020-09-12

7.  Synthesis, hematological, biochemical, and neurotoxicity screening of some mannich base hydrochlorides.

Authors:  Karima Lahbib; Iyadh Aouani; Hafedh Abdelmelek; Soufiane Touil
Journal:  Toxicol Int       Date:  2013-09

8.  Motor skills mediated through cerebellothalamic tracts projecting to the central lateral nucleus.

Authors:  Nobuyuki Sakayori; Shigeki Kato; Masateru Sugawara; Susumu Setogawa; Hotaka Fukushima; Rie Ishikawa; Satoshi Kida; Kazuto Kobayashi
Journal:  Mol Brain       Date:  2019-02-08       Impact factor: 4.041

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.